Refining the management of polycythemia vera.

Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit.

Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics.

Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia.

Alternative Outpatient Chemotherapy Scheduling Method to Improve Patient Service Quality and Nurse Satisfaction.

Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.

New guidelines from the NCCN for polycythemia vera.

The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette.

NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018.